U.S. markets open in 8 hours 30 minutes
  • S&P Futures

    4,241.50
    +10.00 (+0.24%)
     
  • Dow Futures

    33,851.00
    +92.00 (+0.27%)
     
  • Nasdaq Futures

    14,302.50
    +39.50 (+0.28%)
     
  • Russell 2000 Futures

    2,308.50
    +8.20 (+0.36%)
     
  • Crude Oil

    73.17
    +0.09 (+0.12%)
     
  • Gold

    1,774.10
    -9.30 (-0.52%)
     
  • Silver

    25.92
    -0.19 (-0.73%)
     
  • EUR/USD

    1.1930
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.4870
    0.0000 (0.00%)
     
  • Vix

    16.32
    -0.34 (-2.04%)
     
  • GBP/USD

    1.3957
    -0.0007 (-0.05%)
     
  • USD/JPY

    110.9600
    -0.0020 (-0.00%)
     
  • BTC-USD

    32,610.80
    -1,450.74 (-4.26%)
     
  • CMC Crypto 200

    786.06
    -24.13 (-2.98%)
     
  • FTSE 100

    7,074.06
    -15.95 (-0.22%)
     
  • Nikkei 225

    28,861.01
    -13.88 (-0.05%)
     
  • Oops!
    Something went wrong.
    Please try again later.

Roblox Q1 Results Miss Expectations, but Investors Cheer Jump in Activity

·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

By Yasin Ebrahim

Investing.com – Roblox reported Monday first-quarter results that fell short of analyst expectations, but investors were comforted by signs of a ramp up in activity on its gaming-platform, easing fears of slowdown as the economy reopens.    

Roblox (NYSE:RBLX), which made its stock market debut on Mar. 10, rose more than 3% in after-hours trade. 

Roblox delivered a Q1 loss of 46 cents a share on revenue of $384 million, topping expectations for EPS of 13 cents on revenue of $572.6 million.  

Bookings increased 161%, to $652.3 million. 

Daily active users rose 79% in 2020 to 42.1 million and the number of hours that players spend on the app rising 98%, to 9.7 billion.

The company forked out about $118.9 million in fees to game creators, more than double the $44.5 million seen a year earlier.

Related Articles

Roblox Q1 Results Miss Expectations, but Investors Cheer Jump in Activity

No requests to waive Jones Act in wake of Colonial Pipeline shutdown, U.S. says

Novavax again delays COVID-19 vaccine production timeline, shares fall